Answers are grounded in this paper and cite their sources.
Background: Phytochemicals form the basis of research and development of new molecules leading to the development of new novel drugs. In the oncology sector, plants have contributed more than 60% of the anti-cancer drugs, directly or indirectly. The present study Aims and Objectives: was conducted with the objective to explore the antitumor activity of various extracts obtained from dried roots of Centaurea behen L., dried fruits/beads of Elaeocarpus ganitrus Roxb., dried roots of Gloriosa superba L. and dried leaves of Ficus religiosa L. against human lung cancer (A 549) cell lines. Method: Phytoconstituents were extracted by Soxhlet method using hexane, chloroform, methanol and water as solvents. MTT assay was used to nd the anti-proliferative potential of these plant extracts. The trypan blue dye exclusion test was used to determine the number of viable cells present in a cell suspension. Cytotoxic activity was also evaluated against non-cancerous cell lines (MCF-10A). Results: On A-549 cell lines, 93% cell death was reported with G. superba aqueous extract followed by E. ganitrus methanol extract and F. religiosa hexane extract and C. behen aqueous extract with 87%, 81.61% and 75 % cell death respectively. However, none of the extracts showed cytotoxic effect upon testing against normal non-cancerous cell lines (MCF- 10A). Conclusions: The results of the current ndings prove that phytoconstituents present in these plant extracts have high anticancer potential. This study strongly suggests the possibility of medicinal plants as an important source of anticancer drug development.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: